AbbVie Inc.
ABBV
$245.64
$1.840.76%
NYSE
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 13.25% | -9.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.25% | -9.72% | |||
| Cost of Revenue | 1.73% | -7.34% | |||
| Gross Profit | 17.76% | -10.62% | |||
| SG&A Expenses | 1.86% | -8.67% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.10% | -7.05% | |||
| Operating Income | 41.00% | -14.89% | |||
| Income Before Tax | 311.74% | -61.06% | |||
| Income Tax Expenses | 93.57% | -59.91% | |||
| Earnings from Continuing Operations | 418.79% | -61.60% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -50.00% | -300.00% | |||
| Net Income | 419.86% | -61.73% | |||
| EBIT | 41.00% | -14.89% | |||
| EBITDA | 28.48% | -11.69% | |||
| EPS Basic | 424.10% | -61.85% | |||
| Normalized Basic EPS | 44.91% | -18.09% | |||
| EPS Diluted | 422.66% | -61.85% | |||
| Normalized Diluted EPS | 45.24% | -18.37% | |||
| Average Basic Shares Outstanding | 0.00% | -0.28% | |||
| Average Diluted Shares Outstanding | -0.23% | 0.06% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.81% | 1.77% | |||